Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan

INTRODUCTION: During the recent coronavirus disease 2019 (COVID-19) pandemic, preferences for factors associated with vaccines have been evaluated. Three oral antiviral drugs have been approved in Japan for patients with mild-to-moderate I COVID-19 symptoms. Although preferences for the drugs may al...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosogaya, Naoki, Takazono, Takahiro, Kurazono, Kenji, Hiroi, Shinzo, Iwasaki, Kosuke, Takeshima, Tomomi, Ha, Chise, Mukae, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258079/
https://www.ncbi.nlm.nih.gov/pubmed/37303032
http://dx.doi.org/10.1007/s12325-023-02564-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258079/
https://www.ncbi.nlm.nih.gov/pubmed/37303032
http://dx.doi.org/10.1007/s12325-023-02564-4

Ejemplares similares